PACS Group (NYSE:PACS) CEO Sells $5,201,354.45 in Stock

Posted by Scott Moore on Oct 16th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 110,035 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $47.27, for a total value of $5,201,354.45. Following the sale, the chief executive officer owned 54,324,982 shares of the company’s stock, valued at approximately $2,567,941,899.14. The trade was a 0.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total transaction of $10,440.00.
On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75.
On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total transaction of $1,033,395.84.
On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The shares were sold at an average price of $42.51, for a total transaction of $1,107,470.52.
On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The shares were sold at an average price of $41.13, for a total transaction of $1,358,606.16.
On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total transaction of $476,226.67.
On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total transaction of $396,098.36.

PACS Group Stock Performance

PACS traded down $0.82 on Friday, reaching $46.93. The company had a trading volume of 958,006 shares, compared to its average volume of 895,386. PACS Group, Inc. has a 1 year low of $10.31 and a 1 year high of $49.49. The stock has a market capitalization of $7.43 billion, a PE ratio of 27.28, a P/E/G ratio of 1.40 and a beta of -0.08. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The stock has a 50-day moving average price of $43.61 and a 200-day moving average price of $40.37.

PACS Group (NYSE:PACS – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, research analysts forecast that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Institutional Investors Weigh In On PACS Group

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its stake in shares of PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after buying an additional 614,250 shares during the period. Sei Investments Co. raised its stake in PACS Group by 7.4% during the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after acquiring an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after acquiring an additional 89,067 shares during the period. Bank of New York Mellon Corp acquired a new stake in PACS Group during the 2nd quarter worth approximately $8,196,000. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new stake in PACS Group during the 1st quarter worth approximately $6,762,000.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on PACS shares. Royal Bank Of Canada raised their price target on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. UBS Group lifted their price target on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price objective on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Zacks Research downgraded PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, PACS Group currently has an average rating of “Moderate Buy” and an average price target of $58.80.

Get Our Latest Stock Report on PACS Group

About PACS Group

(Get Free Report)

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.